Latest 30 News in the Life Sciences Industry
GlobeNewswire
ANGEL Expands U.S. Water Purification Lineup with New Whole House Water Filtration Systems
08 May 2026
PR Newswire Association LLC.
MENARINI GROUP: THOMAS CUENI APPOINTED NEW MEMBER OF THE BOARD
07 May 2026
GlobeNewswire
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
07 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
GlobeNewswire
CJ Biomaterials and Yuhan-Kimberly Launch World’s First Reusable Nonwoven Paper Towel Made with Amorphous PHA
07 May 2026
GlobeNewswire
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
07 May 2026
PR Newswire Association LLC.
TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE
04 May 2026
GlobeNewswire
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
04 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
30 Apr 2026
GlobeNewswire
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
30 Apr 2026
GlobeNewswire
Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery
29 Apr 2026
GlobeNewswire
Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs
29 Apr 2026
PR Newswire Association LLC.
Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
28 Apr 2026
GlobeNewswire
Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026
28 Apr 2026
GlobeNewswire
Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed
28 Apr 2026
GlobeNewswire
Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial
28 Apr 2026
GlobeNewswire
AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance
27 Apr 2026
PR Newswire Association LLC.
Thirty years of values: the Fair Play Menarini International Award announces its 2026 edition
06 May 2026
PR Newswire Association LLC.
FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
23 Apr 2026
PR Newswire Association LLC.
Servier completes the acquisition of Day One Biopharmaceuticals
23 Apr 2026
PR Newswire Association LLC.
Bracco Imaging and NYU Langone Health Announce Strategic Alliance Agreement to Advance Medical Imaging Innovation
20 Apr 2026
PR Newswire Association LLC.
Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)
19 Apr 2026
PR Newswire Association LLC.
SQ Innovation and FIS Announce Strategic Supply Agreement for Furosemide API
15 Apr 2026
PR Newswire Association LLC.
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
14 Apr 2026
Upcoming Events All Events
- May 2026
- Copenhagen: LSX Nordic Congress
- Basel: Pharma Partnering EU Summit 2026
- London: UK Biotech Day